Published Online: Monday, January 1, 2007

Calling it a "major step forward," the Consumer Healthcare Products Association (CHPA) commended the House of Representatives on passing HR 5280, the Dextromethorphan Distribution Act. Reps Fred Upton (R, Mich) and Rick Larsen (D, Wash) developed and introduced the legislation.

The law prohibits the distribution of raw dextromethorphan, an active ingredient commonly found in OTC cough medicines, to any individuals other than the FDA-registered producers of drugs and devices. "This bipartisan legislation is vital to protecting America's youth from unscrupulous on-line pushers who willingly provide kids with the raw form of dextromethorphan as a means to get high," said Linda A. Suydam, DPA, president of CHPA.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues